Risk Stratification Value of Biomarkers in Patients With Ventricular Arrhythmias - Trial NCT05965375
Access comprehensive clinical trial information for NCT05965375 through Pure Global AI's free database. This phase not specified trial is sponsored by First Affiliated Hospital Xi'an Jiaotong University and is currently Not yet recruiting. The study focuses on Ventricular Arrythmia. Target enrollment is 5000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
First Affiliated Hospital Xi'an Jiaotong University
Timeline & Enrollment
N/A
Oct 31, 2023
May 31, 2027
Primary Outcome
Change in the incidence of MACCE
Summary
The investigation of biomarkers for immune status and metabolic state, as well as host
 microbiota composition, in patients with ventricular arrhythmias before and after
 radiofrequency ablation, can provide new insights for specific and personalized treatment.
 This can help establish early prediction and prognosis models and provide a basis for
 clinically effective diagnosis and treatment.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05965375
Non-Device Trial